Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
5,478
-7,945
-59% -$556K ﹤0.01% 794
2026
Q1
$1.01M Buy
13,423
+4,554
+51% +$363K 0.01% 433
2025
Q4
$699K Sell
8,869
-4,785
-35% -$368K ﹤0.01% 476
2025
Q3
$1.02M Buy
+13,654
New +$1.14M 0.01% 355
2025
Q2
Sell
-3,145
Closed -$299K 651
2025
Q1
$299K Sell
3,145
-651
-17% -$58.4K 0.01% 462
2024
Q4
$322K Buy
3,796
+346
+10% +$31.2K 0.01% 436
2024
Q3
$345K Sell
3,450
-559
-14% -$52.6K 0.01% 359
2024
Q2
$357K Buy
4,009
+317
+9% +$27.1K 0.01% 376
2024
Q1
$308K Buy
3,692
+132
+4% +$10.6K 0.01% 322
2023
Q4
$278K Buy
3,560
+678
+24% +$50.1K 0.01% 403
2023
Q3
$222K Buy
2,882
+386
+15% +$31.7K 0.03% 185
2023
Q2
$205K Buy
+2,496
New +$191K 0.04% 199

Other funds holding ALC

Marex Group's ALC Position: Q2 2026 in Review

Marex Group reduced its Alcon (ALC) stake by 59% in Q2 2026, selling an estimated $556K and leaving 5,478 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Marex Group first reported a position in ALC in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q3 2025. 630 funds tracked by Wall St. Rank hold ALC as of Q2 2026.

  • Marex Group held 5,478 shares of Alcon worth $368K as of Q2 2026.
  • Marex Group sold 7,945 Alcon shares in Q2 2026, an estimated $556K.
  • Alcon made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #794 holding.
  • Marex Group first reported a position in Alcon in Q2 2023 and has held it in 12 quarters since.
  • Marex Group's Alcon position peaked at $1.02M in Q3 2025.
  • 630 funds tracked by Wall St. Rank held Alcon as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.